Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database
Subcutaneous users achieved superior weight loss compared to oral users. Older oral users experienced better weight loss compared to younger users. However, no differences were observed between subcutaneous users.
Authors
- Jonathan Hirohiko Watanabe (ORCID: https://orcid.org/0000-0002-2543-5305)
- Diana Thiara
- Jimmy Kwon
Institutions
- University of California, San Francisco (US)
- University of California, Irvine (US)
- Universidad Católica de Santa Fe (AR)
Publication Details
- Journal
- Expert Review of Endocrinology & Metabolism
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1080/17446651.2025.2462100
- Citations
- 4
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- University of California, Irvine
- Office of the President, University of California